You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
11 November 2026 - Precision oncology company Guardant Health Inc (Nasdaq: GH) announced on Wednesday that it has expanded its Guardant360 Liquid cancer testing capabilities with new epigenomic applications designed to improve treatment selection in ...
11 November 2026 - Jubilant Therapeutics Inc, a US-based, clinical-stage biopharmaceutical company that is advancing precision therapeutics for myeloproliferative neoplasms (MPNs), announced on Tuesday that clinical results from its Phase 1/2 study o...
11 November 2026 - Nuvation Bio Inc (NYSE: NUVB), a New York-based global oncology company involved in cancer treatment, announced on Tuesday that David Hung, MD, founder, president, and chief executive officer of Nuvation Bio, and Philippe Sauvage, ...
11 November 2026 - Abbisko Therapeutics Co Ltd (HKEX code: 02256.HK), a China-based biopharmaceutical company, announced on Tuesday that the US Food and Drug Administration (FDA) has approved PIMJETMI (pimicotinib), a small-molecule colony-stimulatin...
10 November 2026 - Preclinical biotechnology company Omniose announced on Tuesday that it has been acquired by biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN).This acquisition brings Omniose's proprietary bioconjugation ...
10 November 2026 - French vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) on Tuesday reported sustained antibody responses five years after a single dose of its chikungunya vaccine, IXCHIQ, with 94% of 221 evaluable participants maintai...
10 November 2026 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Tuesday that it has received US Food and Drug Administration (FDA) 510(k) clearance and European IVDR CE marking for VITEK PRO, its new automated microb...